Evolution of the Average Target: Virbac

Evolution of the Target Price: Virbac

Changes in Analyst Recommendations: Virbac

1a0a09b1e7.yUF-nye-WkmtKVAlu4JJemkbJd9R-ConpCtVnDGkyf0.nTkk02DoAnj5WAIdjOUtSgdCY-w_wUdWyEgMzXqJqrr4KxSrEN0dMcFRIw~9401275d9b88d36a1a972b7bd370378c
05-11 Virbac continues decline despite positive recommendation Zonebourse
04-17 Virbac: 2026 starts on strong footing Alphavalue
03-19 Stifel sees Virbac as undervalued, sets 440 euro price target Zonebourse
03-18 Virbac in the green following results and outlook Zonebourse
01-20 Virbac beats 2025 targets, lifts 2026 outlook Alphavalue
01-20 Stifel Raises Price Target on Virbac Zonebourse
01-20 Virbac Significantly Outperforms the Market with Annual Revenues and 2026 Targets Zonebourse
25-10-17 Virbac: Q3 crushed doubts about execution ability Alphavalue
25-09-17 The day the Fed resumed its rate cuts Zonebourse
25-09-15 Virbac: Oddo BHF remains positive despite H1 results Zonebourse
25-07-17 Virbac: A healthy Q2 impresses the markets Alphavalue
25-07-03 Oddo BHF Upgrades Virbac to Outperform, Boosts PT MT
25-07-03 Virbac: Oddo BHF upgrades stock Zonebourse
25-04-17 Virbac: brokers' advice following quarterly results Zonebourse
25-04-16 Virbac: Stifel remains bullish after quarterly results Zonebourse
25-04-16 Virbac: Decent Q1; Clarity on US tariff exposure was a key takeaway Alphavalue
25-04-16 Virbac: Stifel still buying after Q1 results Zonebourse
25-03-17 Virbac: Oddo BHF remains 'neutral', confirms its target Zonebourse
25-03-17 Virbac: 2024 profitability somewhat exceeded expectations; stock re-rating underway Alphavalue
25-03-17 Virbac: Stifel raises its recommendation Zonebourse
25-01-17 Virbac: 2024 top-line goals met; uninspiring 2025 outlook could be raised later Alphavalue
25-01-17 Oddo BHF Downgrades Virbac to Neutral, Cuts PT MT
24-11-04 Virbac: Stifel lowers its target price for the stock Zonebourse
24-10-18 Virbac: Market’s anxiety over the Q3 miss was not warranted Alphavalue
24-10-01 Virbac: Making good strides Alphavalue

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+53.26%
+30.24%
- +71.44%
+37.37%
+22.99%
- +46.25%
+32.1%
+33.14%
+27.83%
Average +39.40%
Weighted average by Cap. +47.49%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
342.50EUR
Average target price
412.88EUR
Spread / Average Target
+20.55%
High Price Target
440.00EUR
Spread / Highest target
+28.47%
Low Price Target
368.00EUR
Spread / Lowest Target
+7.45%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

alphavalue Abhishek Raval
ODDO BHF
TP ICAP Midcap
Stifel Nicolaus
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
342.50EUR
Average target price
412.88EUR
Spread / Average Target
+20.55%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!